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Pigmented epithelioid melanocytoma (PEM), or animal-type melanoma, is an unusual variant of mela-
noma which has been reported to have indolent behavior and a relatively good prognosis. We report
a 12-year-old girl with PEM on the third ﬁnger web of her right hand. Histopathologically, it was
composed of heavily pigmented dermal epithelioid and spindled melanocytic tumor cells. A sentinel
lymph node biopsy was negative, and no recurrence was noted 1 year later. We reviewed 173 previously
published cases of PEM or so-called animal-type melanoma in the literature. Among the 173 cases and
our case, extremities were the most common sites of occurrence (52/129, 40.3%), and most of the depth
of invasions were Clark level IV and V [76/114 (66.7%) and 33/114 (28.9%), respectively]. Lymph nodes
metastasis was noted in 39/89 (43.8%) of the cases being investigated. Only two cases died of the disease
with visceral metastasis. Thus, a more advanced level of invasion and the presence of lymph node
metastasis did not imply a deﬁnitely malignant clinical course, because spreading beyond lymph nodes
was rare (5/174, 2.9%). However, long-term follow-up with more cases and further research are needed to
fully delineate the true biological nature of this pigmented melanocytic tumor.
Copyright  2012, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Pigmented epithelioid melanocytoma (PEM) is an unusual variant
of malignant melanoma with relatively indolent behavior. It was
ﬁrst described by Dick,1 who noted its predilection for gray horses
and named it as “equine-type melanoma” in 1832. In 1925, Darier2
ﬁrst described this kind of tumor in humans, and introduced the
name “melanosarcoma.” Since then, a small number of cases have
been reported, and the name “animal-type melanoma” has been
used. In 2004, Zembowicz3 gave it the name “pigmented epithe-
lioid melanocytoma” which was proposed to include animal-type
melanoma and epithelioid blue nevus as malignant and benign
ends of this histological spectrum. In 2006, Antony4 named it as
“pigment synthesizing melanoma.” He thought that the name PEM
implied a benign tumor according to the nomenclature system.
However, PEM is still themost common name being used in current
literature.t of Dermatology, Chi Mei
g District, Tainan City 710,
0 3706.
iwanese Dermatological AssociatioPEM is extremely rare. It affects all age groups. The prognosis is
relatively good compared to conventional malignant melanoma.
However, there are only limited cases and results of long-term
follow-up, and the role of sentinel lymph node biopsy (SLNB) in
the disease is still controversial. We reviewed 173 cases in the
literature, regarding the results of gender ratio, location, Clark’s
level of invasion, and outcomes such as lymph node metastasis,
distant metastasis and follow-up.
Case presentation
A 12-year-old Taiwanese girl (Fitzpatrick type IV) presentedwith an
asymptomatic brown-black nodule, measuring 0.4 0.4 cm, on the
third ﬁnger web of her right hand (Figure 1A). The nodule had been
observed for 3e4 years, increasing in size in a few months. There
was no past history or family history of malignant melanoma, blue
nevus or Carney complex. No palpable lymph node or history of
frequent sun exposure was noted. The lesion was excised and
histology showed predominant formation of heavily pigmented
epithelioid cells (Figures 1B and 1C) and some spindled cells with
large nuclei, prominent nucleoli (Figure 1D) and rare mitosis
(Figure 1D, arrow). Ulceration was also noted (Figure 1B). Neithern. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 (A) A 0.4 0.4 cm, brown-black nodule on the third ﬁngerweb of the right hand; (B) the scanning view of the section showed an ulcerated and heavily pigmented lesion (H&E,
40); (C) the tumor is composed of predominantly heavily pigmented polygonal epithelioid cells with large nuclei and prominent nucleoli. Heavily pigmented spindled cells constitute
the minor component (H&E, 400); (D) the neoplastic cells demonstrate round nuclei with prominent nucleoli. Mitosis is rare, but could be found in the section (arrow) (melanin
bleached H&E, 400); (E) focal vascular invasion (arrow) at the junction of deep dermis and subcutis (melanin bleached H&E, 200); (F) the tumor cells were positive for S-100 protein
(200); (G) the tumor cells were negative for HMB-45 (200); (H) the tumor cells were negative forMelan-A (200); (I) immunohistochemical stain of the specimenwith Ki-67 revealed
some positive immunoreactivity of the tumor cells with low proliferative index (6%; 400); (J) One year after wide excisionwith full-thickness skin graft, therewas no local recurrence.
However, due to the disﬁgured lesion, the patient wore a glove at all times, and a dividing line of fair-colored and tan-colored skin on the forearm was noted (arrow).
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vascular invasion was seen at the junction of deep dermis and
subcutis (Figure 1E, arrow). Tumor cells were positive for S-100
protein (Figure 1F), but negative for HMB-45 (Figure 1G) and
Melan-A (Figure 1H). The Ki-67 proliferative index was low
(approximately 6%, Figure 1I). A pigmented epithelioid melanocy-
toma, so-called animal-type melanoma, was diagnosed. The depth
of invasionwas classiﬁed as Clark level V, with maximum thickness
of 3.8 mm. Wide excision with sentinel lymph node sampling and
full-thickness skin graft was performed at another hospital. No
residual tumor was found, and the sentinel lymph node was
negative. Positron emission tomography scan was also negative.
The patient was followed for 1 year, and neither local recurrence
nor metastasis occurred (Figure 1J).
Discussion
PEM is a distinctive clinicopathological variant of melanocytic
tumor of unknown malignant potential. It is characterized by its
unique feature of indolent behavior compared to conventional
melanoma. While Zembowicz et al.3 reported an equal sex predi-
lection for younger individuals without ethnic predominance,
Antony et al.4 reported that middle-aged to old adults have
a predilection for the disease. Extremities were the most common
sites of occurrence, followed by trunk and head and neck.3,4
Histopathologically, these lesions often have a wedge-shaped
conﬁguration and are composed of heavily pigmented dermal
melanocytic tumor cells with a mixture of epithelioid and spindled
cells. Mitosis can be seen, but is rare. The histopathological differ-
ential diagnoses of PEM include cellular blue nevus, malignant blue
nevus, Spitz nevus, deep penetrating nevus and epithelioid blue
nevus. The most speciﬁc differentiating feature between PEM and
cellular blue nevus is the presence of abundant epithelioid cells in
PEM.5 However, it is challenging to differentiate between PEM and
malignant blue nevus, since they both have atypical epithelioid
cells. The presence of signiﬁcant nuclear pleomorphism, hyper-
chromatism, prominent eosinophilic nucleoli, brisk mitotic activity,
atypical mitoses and tumor necrosis are important features for
malignant blue nevus. Besides, malignant blue nevus is classically
deﬁned as malignant melanoma arising within a preexisting blue
nevus or the site of prior biopsy/excision of a blue nevus.5 Spitz
nevus usually presents with maturation and prominent demarca-
tion, which can be distinguished from PEM.4 Deep penetrating
nevus is a distinctive deeply pigmented lesion showing overlapping
features with blue nevus and Spitz nevus.6 Histologically, deep
penetrating nevus shows a typical wedge-shaped, deeply pig-
mented dermal tumor with a junctional component. Tumor cells
are arranged in nests or bundles and have a short spindle-shaped
or, less commonly, round morphology. In addition, a thin rim of
sustentacular cells is present around the edges of many nests. One
characteristic feature of deep penetrating nevus, is the extension of
melanocytes along the path of adnexal structures, blood vessels
and nerve bundles, which is absent in PEM.
Epithelioid blue nevus, which is associated with the Carney
complex, but also occurs sporadically, is described as being
histopathologically indistinguishable from PEM, and the relation-
ship between these two entities is still not entirely clear.3e5
Zembowicz et al.3 proposed the term PEM to compose of animal-
type melanoma and epithelioid blue nevus as malignant and
benign ends of this histological spectrum. Murali et al.7 suggested
that a subset of epithelioid blue nevus remained and was distinct
from PEM by less cell density and less pigmentation. Zembowicz
et al.3 mentioned that ulceration was the only feature more
common in PEM than epithelioid blue nevus of Carney complex. In
our case, the tumor was highly cellular, heavily pigmented andshowed cellular atypia with ulceration, and, in our opinion, was
best considered as PEM.
Molecular testing of histologically ambiguous primary cuta-
neous melanocytic tumors by using techniques such as compara-
tive genomic hybridization or ﬂuorescence in situ hybridization
(FISH) may assist in establishing a diagnosis of melanoma if
multiple chromosomal aberrations are identiﬁed.8 However, there
was still a limited result in the ﬁeld of PEM. There were only two
cases of congenital PEM being studied by FISH, and one had focal
FISH positivity.9 This study revealed that there were still limits in
the technique for the diagnosis of PEM. Thus, a deﬁnitive diagnosis
for puzzling lesions such as PEM should not rely on molecular data
alone. The associations between clinical, histopathological and FISH
data are needed.9 Another molecular study showed a loss of
expression of protein kinase A regulatory subunit 1a (R1a coded by
the PRKAR1A gene) in 28 of 34 (82%) PEMs and in 8 of 8 Carney
complex-associated epithelioid blue nevus, whereas R1a was
expressed in 291 of 292 various benign and malignant non-PEM
melanocytic lesions and in 5 of 5 equine melanomas.10 The
results of these studies suggested that PEM and Carney complex-
associated epithelioid blue nevus are closely related neoplasms.
Although being a morphological mimic, PEM is a distinct melano-
cytic tumor that differs in molecular pathogenesis from cellular
blue nevi, malignant blue nevi, Spitz nevi, deep penetrating nevi,
melanomas of various types and equine melanomas.
We reviewed 17 literature publications from the year 1999 to
2010 and identiﬁed 173 previously reported cases (Table 1). Among
the cases with detailed data (including our case), there were 72
(55.8%) females and 57 (44.2%) males. There were four cases of
congenital PEM. The most common sites of occurrence were the
extremities (52/129; 40.3%), followed by trunk (36/129; 27.9%) and
head and neck (36/129; 27.9%). Most of the tumors at the time of
diagnosis involved Clark’s level IV (76/114; 66.7%) or Clark’s level V
(33/114; 28.9%). Among the 174 cases, 39 cases (22.4%) had lymph
node metastasis; only 5 cases (2.9%) had spread beyond lymph
nodes. The most common site of visceral metastasis was liver (4/5,
80%). Two cases (1.1%) died of the disease due to visceral metastasis
during follow-up (Table 2). Although presenting at deep levels, PEM
has better prognosis than conventional melanoma.
The true nature of PEM remains controversial. Many consider it
a tumor of uncertain malignant potential or possibly a low-grade
malignancy. Although it has a tendency to have deep invasion
and even spread to regional lymph nodes, distant metastasis is rare.
Even if it recurs or metastasizes, it has a better prognosis compared
to conventional malignant melanoma with the same depth of
invasion.3e5,11 Ludgate et al.11 and Zembowicz et al.3 reported SLNB
positive rates of 47% (8/17) and 46% (11/24), respectively. However,
in contrast to these two studies, Orlandi et al.12 and Scolyer et al.13
reported no positive SLNB in 7 and 5 patients with PEM, respec-
tively (Table 1). Among the 174 cases we reviewed, the positive rate
of lymph node metastasis either conﬁrmed by SLNB or complete
lymph node dissection (CLND) was 43.8% (39/89), accounting for
22.4% of the total number of cases. The variation in these results
may be due to the small number of cases in previous reports, and
the criteria for performing a SLNB/CLND not being clearly estab-
lished. Thus, the positive rate in cases undergoing lymph nodes
sampling or dissection may be over-estimated due to deeper tumor
cell invasion or a more progressive clinical course. Regardless of the
relatively high rate of lymph node metastasis, there were only 2.9%
of cases whose disease had spread beyond the lymph nodes
(Table 2). Thus, whether SLNB or CLND is needed for all cases of
PEM is still controversial. Some suggested that PEM may not need
to bemanaged as aggressively as conventional melanoma, due to its
indolent behavior,14 while others recommended SLNB as a “diag-
nostic procedure” in an attempt to better recognize the biological
Table 1 Previous reports of pigmented epithelioid melanocytoma/animal-type melanoma and our patient.
Author Year No. of
cases
Sex Location Clark level Outcome Follow-up
Ludgate et al.11 2010 22 M: 13
F: 9
Head & neck: 6
Trunk: 6
Extremities: 9
Genitalia: 1
I: 1
III: 2
IV: 16
V: 3
SLNB (þ): 8/17 (47%)
Recurrence: 4 cases (18%)
(2 had distant metastasis, and 1 died of
visceral metastasis 2.5 y following the
initial diagnosis.)
Median: 17.6 mo
Battistella et al.9 2010 2 M: 1
F: 1
Head & neck: 1
Extremity: 1
V: 1
Another N/A
Congenital PEM.
SLNB was not performed in both cases.
26 mo and 15 mo, respectively
Yun et al.16 2010 1 F:1 Head & neck: 1 V: 1 Congenital PEM. Excision was performed at
5 mo, regional LN metastasis at 7 mo and
the patient underwent 8 courses of
CVD-BIO biochemotherapy*. Tumor-free
for 20 mo after excision.
20 mo
Orlandi et al.12 2009 7 M: 2
F: 5
Head & neck: 3
Trunk: 3
Extremity: 1
IV: 1
V: 6
SLNB (þ): 0/7 (0%)
One died of cardiac failure without evidence
of disease progression.
3 y (4/7) and 5 y (3/7)
Mandal et al.15 2009 26 M: 9
F: 17
Head & neck: 7
Trunk: 6
Extremities: 12
Genitalia: 1
III: 2
IV: 19
V: 5
SLNB or CLND (þ): 8/20 (40%)
Alive and free of disease during follow-up.
Median : 67 mo (range 39e216 mo)
Ito et al.17 2009 2 F: 2 Trunk: 2 V: 2 SLNB was not performed in both cases.
Alive and free of disease during follow-up.
22 mo and 16 mo, respectively
Vezzoni et al.18 2008 1 F: 1 Trunk :1 IV: 1 SLNB (-).
Alive and free of disease during follow-up
N/A
Sabah et al.19 2007 1 F: 1 Extremity: 1 V: 1 Local recurrence occurred 9 y after previous
simple excision. SLNB(-)
Alive and free of disease during follow-up.
46 mo
Antony et al.4 2006 14 M: 8
F: 6
Head & neck: 5
Trunk: 3
Extremities: 6
Only mentioned
the Breslow level,
no Clark level.
SLNB or CLND(þ): 5
Distant metastasis (liver): 1
Local recurrence: 3
No recurrence or metastasis: 6
No death during follow-up.
Median 5 y (range 1e17 y)
Lu et al.20 2006 1 F: 1 Head & neck: 1 IV: 1 SLNB was not performed.
Alive and free of disease during follow-up.
3 mo
Ward et al.21 2006 1 M: 1 Trunk: 1 IV: 1 SLNB (-).
Alive and free of disease during follow-up.
6 mo
Howard et al.22 2005 2 M: 1
F: 1
Head & neck: 1
Extremity: 1
IV: 2 CLND (þ): 1, with radiation therapy and
intravenous alfa-interferon therapy.
Alive and free of disease during follow-up.
The ﬁrst case was followed up
for 60 mo; another one was N/A.
Zemboxicz et al.3 2004 40
(with 41
lesions)
M: 18
F: 22
Head & neck: 10
Trunk: 11
Extremities: 18
Genitalia: 2
IV: 30
V: 11
SLNB (þ): 11/24 (46%)
1 case: congenital PEM with hepatic
metastasis discovered at presentation, is
well during the 3-y follow-up.
No death during follow-up.
Mean: 32 mo
Scolyer et al.13 2004 45 N/A N/A N/A SLNB (þ): 0/5 (0%).
CLND (þ): 1/1
N/A
Kazakov et al.23 2004 1 F: 1 Extremity: 1 IV: 1 SLNB (þ).
Alive and free of disease during follow-up.
24 mo
Requena et al.24 2001 1 M: 1 Trunk: 1 V: 1 SLNB (þ), had chemotherapy with
interferon alfa-2b.
Alive and free of disease during follow-up.
4 mo
Crowson et al.25 1999 6 M: 3
F: 3
Head & neck: 1
Trunk: 2
Extremity: 1
Genitalia: 1
(another one:
unknown)
IV: 4
V: 1
(another one:
unknown)
1 died of the disease with metastases to
regional LN, liver, and lungs.
1 had regional LN metastasis, but was alive
and well.
1 had local recurrence, but was lost to
follow-up.
1 had chest mass, but had not yet been
investigated.
2 were alive and free of disease during
follow-up.
From 5 mo to 4 y
Our patient 2011 1 F:1 Extremity: 1 V: 1 Alive and free of disease during follow-up. 12 mo
CLND ¼ complete lymph node dissection; F ¼ female; LN ¼ lymph nodes; M ¼ male; N/A ¼ not available; SLNB ¼ sentinel lymph node biopsy.
* Two 21-day cycles of chemotherapy and three cycles of interleukin-2 and interferon-alfa every 6 weeks.
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forming a SLNB in PEM that is greater than 1 mm in Breslow depth
or 0.75e1 mm with other adverse features such as ulceration or
a highmitotic rate. The longest follow-up to datewas reported after
a median follow-up period of 67 months (range from 39 to 216
months) of 26 patients by Mandal et al.15 All of these patients were
alive and free of disease during the follow-up period. These resultsshowed that the presence of lymph node metastases in PEM does
not necessarily imply a malignant clinical course. Examination of
sentinel lymph nodes by lymphoscintigraphy and assessment by
clinical examination and ultrasound for early detection of metas-
tasis, rather than invasive SLNB, have been suggested.15
In summary, although there are still debates on the nomencla-
ture of this entity, PEM is the most common name used currently; it
Table 2 Summary of 173 previously reported cases of pigmented epithelioid
melanocytoma/animal-type melanoma and our case.
Number of cases 174
Gender Male: 57/129 (44.2%)
Female: 72/129 (55.8%)
Locations of the lesions Extremities: 52/129 (40.3%)
Head & neck: 36/129 (27.9%)
Trunk: 36/129 (27.9%)
Genitalia: 5/129 (3.9%)
Clark level of the lesions at diagnosis I: 1 /114 (0.9%)
II: 0 /114 (0%)
III: 4 /114 (3.5%)
IV: 76 /114 (66.7%)
V: 33 /114 (28.9%)
Underwent sentinel lymph node biopsy
or complete lymph node dissection
89
ePositive result 39 (43.8% of investigated cases);
(22.4% of the total cases)
Spread beyond lymph nodes 5 (2.9%)*
Follow-up (range 0 to 216 mo)
eAlive and well 171 (98.3%)
eDeath 3 (1.7%)
/Only 2 cases (1.1%) died of
the diseasey
ATM ¼ animal-type melanoma; PEM ¼ pigmented epithelioid melanocytoma.
* Three cases with hepatic metastasis, and one case with both hepatic and lung
metastasis. Another patient’s site of metastasis was not available.
y One died of visceral metastasis (speciﬁc site was not available) 2.5 years after
the initial diagnosis, another died of hepatic and lung metastasis (the survival time
was not available).
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grade melanoma. PEM is characterized by a predominantly intra-
dermal deeply pigmented melanocytic lesion, composed mainly of
epithelioid and spindled cells. Some cytologic atypia can be found,
but mitotic activity is low. PEM may involve regional lymph nodes,
but it has a limited ability to spread beyond the lymph nodes.
Although it showed indolent behavior and an overall good prog-
nosis in the 174 cases we reviewed, its potential for aggressive
behavior should not be ignored. Whether SLNB should be per-
formed as a staging procedure in every case of PEM remains
controversial. Longer periods of follow-up with more cases and
further molecular studies for PEM are needed to fully delineate the
true biological nature of this disease.
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